Cadence, a digital health care startup that specializes in virtual patient monitoring, raises $100M led by Coatue Management at a $1B valuation
Context & Ripple Effects
Cadence's $100M round lands at the tail end of a year in which remote-care startups repeatedly reset their own marks: Hinge Health raised $400M at a $6.2B valuation in October with Coatue already on the cap table, and Virta's Series E had doubled its valuation to $2B just seven months after a ~$1.1B round.
The throughline is Coatue itself — the Tiger Global spinout is now a repeat lead in virtual care, and Cadence's $1B entry valuation puts it at the same threshold Virta crossed a year earlier, but in far less time.
First-order effects
- Cadence gains nine figures of growth capital for its virtual patient monitoring business and joins the unicorn club at a $1B valuation, giving it funding parity with earlier entrants like Virta and Vida Health.
Second-order effects
- Chronic-condition monitoring rivals — Virta, Vida, Hinge Health — now compete against a newly capitalized peer, while Coatue's second digital health lead of the quarter signals the firm will keep setting price floors in the category.
Third-order effects
- If the 2021 cadence holds — successive rounds at rising valuations across Carbon Health, Hinge, Virta, and now Cadence — remote monitoring consolidates into a small set of heavily funded platforms, raising the bar for any new monitoring startup to reach scale without a comparable raise.
The trend: Venture capital is concentrating in remote patient monitoring, with crossover firms like Coatue leading repeated mega-rounds that turn virtual care startups into unicorns within a single funding cycle.